David Joseph Topper net worth and biography

David Topper Biography and Net Worth

Mr Topper joined Arcutis in April 2024 as chief financial officer and is responsible for overseeing and managing all financial operations for Arcutis. Mr Topper brings more than 40 years of professional experience in banking, investment management, and corporate operations, with a proven record of leading and advising on capital markets activities including initial public offerings, follow-on offerings, mergers and acquisitions, debt financings, and derivatives. Prior to Arcutis, Mr Topper was CFO of Inmagene Biopharmaceuticals, a global clinical stage pharmaceutical company. Prior to Inmagene, Mr Topper held significant positions in various organizations, including serving as a partner for capital markets at General Atlantic and Frazier Healthcare Life Sciences. He also acted as CFO and board director at Frazier Life Sciences Acquisition Corp. Previously, he worked for six years at J.P. Morgan as co-head of Equity Capital Markets, Vice Chairman, and Chairman of the Commitments Committee. Prior to JPM, Mr Topper was at Morgan Stanley for 22 years, where he held a number of leadership positions including co-head of Equity Capital Markets and managing director. Mr Topper holds an MBA from Stanford University and a BA from Duke University.

What is David Joseph Topper's net worth?: The estimated net worth of David Joseph Topper is at least $2.32 million as of September 24th, 2024. Mr. Topper owns 158,374 shares of Arcutis Biotherapeutics stock worth more than $2,315,428 as of March 15th. This net worth estimate does not reflect any other investments that Mr. Topper may own. Learn More about David Joseph Topper's net worth.
How old is David Joseph Topper?: Mr. Topper is currently 66 years old. There are 6 older executives and no younger executives at Arcutis Biotherapeutics. The oldest executive at Arcutis Biotherapeutics is Dr. Bhaskar Chaudhuri Ph.D., Co-Founder & Independent Director, who is 69 years old. Learn More on David Joseph Topper's age.
How do I contact David Joseph Topper?: The corporate mailing address for Mr. Topper and other Arcutis Biotherapeutics executives is 2945 TOWNSGATE ROAD SUITE 110, WESTLAKE VILLAGE CA, 91361. Arcutis Biotherapeutics can also be reached via phone at 805-418-5006 and via email at ir@arcutis.com. Learn More on David Joseph Topper's contact information.
Has David Joseph Topper been buying or selling shares of Arcutis Biotherapeutics?: David Joseph Topper has not been actively trading shares of Arcutis Biotherapeutics over the course of the past ninety days. Most recently, David Joseph Topper sold 11,626 shares of the business's stock in a transaction on Tuesday, September 24th. The shares were sold at an average price of $9.48, for a transaction totalling $110,214.48. Following the completion of the sale, the chief financial officer now directly owns 158,374 shares of the company's stock, valued at $1,501,385.52. Learn More on David Joseph Topper's trading history.
Who are Arcutis Biotherapeutics' active insiders?: Arcutis Biotherapeutics' insider roster includes Patrick Burnett (Insider), Scott Burrows (CFO), Bhaskar Chaudhuri (Director), Terrie Curran (Director), Larry Edwards (Insider), Masaru Matsuda (General Counsel), David Topper (CFO), Patricia Turney (SVP), Todd Watanabe (CEO), and Howard Welgus (Director). Learn More on Arcutis Biotherapeutics' active insiders.
Are insiders buying or selling shares of Arcutis Biotherapeutics?: During the last year, Arcutis Biotherapeutics insiders bought shares 1 times. They purchased a total of 1,093 shares worth more than $7,771.23. During the last year, insiders at the sold shares 25 times. They sold a total of 204,162 shares worth more than $2,214,551.74. The most recent insider tranaction occured on March, 3rd when insider Patrick Burnett sold 2,819 shares worth more than $36,731.57. Insiders at Arcutis Biotherapeutics own 9.5% of the company. Learn More about insider trades at Arcutis Biotherapeutics.
Information on this page was last updated on 3/3/2025.

David Joseph Topper Insider Trading History at Arcutis Biotherapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/24/2024	Sell	11,626	$9.48	$110,214.48	158,374

David Joseph Topper Buying and Selling Activity at Arcutis Biotherapeutics

Arcutis Biotherapeutics Company Overview

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $14.62

$14.51

$15.38

50 Day Range

MA: $13.52

$11.40

$15.76

2 Week Range

Now: $14.62

$6.99

$16.20

Volume

1,689,885 shs

Average Volume

2,433,515 shs

Market Capitalization

$1.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48

David Topper Biography and Net Worth

What is David Joseph Topper's net worth?

How old is David Joseph Topper?

How do I contact David Joseph Topper?

Has David Joseph Topper been buying or selling shares of Arcutis Biotherapeutics?

Who are Arcutis Biotherapeutics' active insiders?

Are insiders buying or selling shares of Arcutis Biotherapeutics?